{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:04:10Z","timestamp":1766023450246,"version":"3.48.0"},"reference-count":51,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Physiol Pathophysiol Pharmacol"],"DOI":"10.62347\/wshw8932","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:05:49Z","timestamp":1757318749000},"page":"104-115","source":"Crossref","is-referenced-by-count":0,"title":["Alpha-N-acetylgalactosaminidase in cancer: diagnostic applications and related treatment strategies"],"prefix":"10.62347","volume":"17","author":[{"given":"Fatemeh","family":"Keshmiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"167932","DOI":"10.1016\/j.jmb.2022.167932","article-title":"From lysosomal storage disorders to Parkinson&#x2019;s disease-challenges and opportunities","volume":"435","author":"M&#xE4","year":"2023","unstructured":"M&#xE4;chtel R, Boros FA, Dobert JP, Arnold P and Zunke F. From lysosomal storage disorders to Parkinson&#x2019;s disease-challenges and opportunities. J Mol Biol 2023; 435: 167932.","journal-title":"J Mol Biol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/md16050155","article-title":"The Effect of fucoidan from the brown alga Fucus evanescence on the activity of &#x3B1;-N-acetylgalactosaminidase of human colon carcinoma cells","volume":"16","author":"Bakunina","year":"2018","unstructured":"Bakunina I, Chadova O, Malyarenko O and Ermakova S. The Effect of fucoidan from the brown alga Fucus evanescence on the activity of &#x3B1;-N-acetylgalactosaminidase of human colon carcinoma cells. Mar Drugs 2018; 16: 155.","journal-title":"Mar Drugs"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100537","DOI":"10.1016\/j.ctarc.2022.100537","article-title":"Immunotherapy with GcMAF revisited - a critical overview of the research of Nobuto Yamamoto","volume":"31","author":"Albracht","year":"2022","unstructured":"Albracht SP. Immunotherapy with GcMAF revisited - a critical overview of the research of Nobuto Yamamoto. Cancer Treat Res Commun 2022; 31: 100537.","journal-title":"Cancer Treat Res Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/nu13041208","article-title":"Association of vitamin D receptor and vitamin D-binding protein polymorphisms with familial breast cancer prognosis in a mono-institutional cohort","volume":"13","author":"Aristarco","year":"2021","unstructured":"Aristarco V, Johansson H, Gandini S, Macis D, Zanzottera C, Tolva G, Feroce I, Accornero C, Bonanni B, Guerrieri-Gonzaga A and Serrano D. Association of vitamin D receptor and vitamin D-binding protein polymorphisms with familial breast cancer prognosis in a mono-institutional cohort. Nutrients 2021; 13: 1208.","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3390\/ijms23084249","article-title":"Nanoliposomes in cancer therapy: marketed products and current clinical trials","volume":"23","author":"Tal&#xE9","year":"2022","unstructured":"Tal&#xE9;ns-Visconti R, D&#xED;ez-Sales O, de Juli&#xE1;n-Ortiz JV and N&#xE1;cher A. Nanoliposomes in cancer therapy: marketed products and current clinical trials. Int J Mol Sci 2022; 23: 4249.","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/15622975.2022.2124451","article-title":"Low &#x3B1;-N-acetylgalactosaminidase plasma concentration correlates with the presence and severity of the bipolar affective disorder","volume":"24","author":"Yilmaz","year":"2023","unstructured":"Yilmaz S and &#xD6;ner P. Low &#x3B1;-N-acetylgalactosaminidase plasma concentration correlates with the presence and severity of the bipolar affective disorder. World J Biol Psychiatry 2023; 24: 187-194.","journal-title":"World J Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Y&#x131;lmaz S and &#xD6;ner P. Could low &#x3B1;-N-acetylgalactosaminidase plasma concentration cause schizophrenia? World J Biol Psychiatry 2023; 24: 70-77.","DOI":"10.1080\/15622975.2022.2070667"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.1002\/jcb.28317","article-title":"Evaluation of vitamin D(3) deficiency: a population-based study in northeastern Iran","volume":"120","author":"Esmaeili","year":"2019","unstructured":"Esmaeili SA, Mohammadian S, Radbakhsh S, Momtazi-Borojeni AA, Kheirmand Parizi P, Atabati H, Mardani F, Saburi E and Moghaddam AS. Evaluation of vitamin D(3) deficiency: a population-based study in northeastern Iran. J Cell Biochem 2019; 120: 10337-10341.","journal-title":"J Cell Biochem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"110293","DOI":"10.1016\/j.mehy.2020.110293","article-title":"Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: lesson learned from HIV","volume":"144","author":"Spadera","year":"2020","unstructured":"Spadera L and Spadera M. Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: lesson learned from HIV. Med Hypotheses 2020; 144: 110293.","journal-title":"Med Hypotheses"},{"key":"ref9","unstructured":"Saburi E, Saburi A and Ghanei M. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside. Caspian J Intern Med 2017; 8: 228-238."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Mohamad SB, Nagasawa H, Uto Y and Hori H. Erratum to &#x201C;Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation&#x201D;: [Comp. Biochem. Physiol. A 132 (2002) 1-8]. Comp Biochem Physiol A Mol Integr Physiol 2003; 134: 481.","DOI":"10.1016\/S1095-6433(02)00190-3"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0304-3835(00)00502-4","article-title":"Serum &#x3B1;-N-acetylgalactosaminidase is associated with diagnosis\/prognosis of patients with squamous cell carcinoma of the uterine cervix","volume":"158","author":"Reddi","year":"2000","unstructured":"Reddi AL, Sankaranarayanan K, Arulraj HS, Devaraj N and Devaraj H. Serum &#x3B1;-N-acetylgalactosaminidase is associated with diagnosis\/prognosis of patients with squamous cell carcinoma of the uterine cervix. Cancer Lett 2000; 158: 61-64.","journal-title":"Cancer Lett"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.micinf.2005.01.015","article-title":"Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus","volume":"7","author":"Yamamoto","year":"2005","unstructured":"Yamamoto N and Urade M. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus. Microbes Infect 2005; 7: 674-681.","journal-title":"Microbes Infect"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1089\/aid.2006.22.262","article-title":"Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1","volume":"22","author":"Yamamoto","year":"2006","unstructured":"Yamamoto N. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1. AIDS Res Hum Retroviruses 2006; 22: 262-271.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"111951","DOI":"10.1016\/j.ejmech.2019.111951","article-title":"Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance","volume":"187","author":"Mortazavi","year":"2020","unstructured":"Mortazavi H, Nikfar B, Esmaeili SA, Rafieenia F, Saburi E, Chaichian S, Heidari Gorji MA and Momtazi-Borojeni AA. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance. Eur J Med Chem 2020; 187: 111951.","journal-title":"Eur J Med Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"110459","DOI":"10.1016\/j.biopha.2020.110459","article-title":"Potential inhibitory effect of lycopene on prostate cancer","volume":"129","author":"Mirahmadi","year":"2020","unstructured":"Mirahmadi M, Azimi-Hashemi S, Saburi E, Kamali H, Pishbin M and Hadizadeh F. Potential inhibitory effect of lycopene on prostate cancer. Biomed Pharmacother 2020; 129: 110459.","journal-title":"Biomed Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s12098-015-2019-5","article-title":"Blood group change in pediatric leukemia: a rare phenomena","volume":"83","author":"Radhakrishnan","year":"2016","unstructured":"Radhakrishnan V, Mishra S, Bhaskar N and Sagar T. Blood group change in pediatric leukemia: a rare phenomena. Indian J Pediatr 2016; 83: 874.","journal-title":"Indian J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Terwilliger T and Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 2017; 7: e577.","DOI":"10.1038\/bcj.2017.53"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Waleed MS and Sadiq W. Multiple myeloma and change of ABO blood group type: a case report. Cureus 2020; 12: e10654.","DOI":"10.7759\/cureus.10654"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/08998280.2017.11929536","article-title":"Blood group change in acute myeloid leukemia","volume":"30","author":"Nambiar","year":"2017","unstructured":"Nambiar RK, Narayanan G, Prakash NP and Vijayalakshmi K. Blood group change in acute myeloid leukemia. Proc (Bayl Univ Med Cent) 2017; 30: 74-75.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0213-9626(08)70060-X","article-title":"Loss of A, B, and H antigens in oral cancer","volume":"27","author":"Biondi","year":"2008","unstructured":"Biondi C, Campi C, Escovich L, Borr&#xE1;s SG, Racca A and Cotorruelo C. Loss of A, B, and H antigens in oral cancer. Inmunologia 2008; 27: 127-131.","journal-title":"Inmunologia"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ayyazuddin M and Khan Q. An interesting case of blood group switch after breast cancer therapy. Discoveries Reports 2020; 3: e9.","DOI":"10.15190\/drep.2020.3"},{"key":"ref22","unstructured":"Amini M, Fatah SH and Kalantari M. ABO blood groups and prognosis of breast cancer: a case-control study in Arak\/Iran. group 2010; 6: 15-16."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/asheducation-2014.1.410","article-title":"Flamethrowers: blood cells and cancer thrombosis risk","volume":"2014","author":"Pabinger","year":"2014","unstructured":"Pabinger I and Posch F. Flamethrowers: blood cells and cancer thrombosis risk. Hematology Am Soc Hematol Educ Program 2014; 2014: 410-417.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Albracht SPJ, Allon E and van Pelt J. Multiple exo-glycosidases in human serum as detected with the substrate DNP-&#x3B1;-GalNAc. I. A new assay for lysosomal &#x3B1;-N-acetylgalactosaminidase. BBA Clin 2017; 8: 84-89.","DOI":"10.1016\/j.bbacli.2017.10.001"},{"key":"ref25","unstructured":"Saburi E, Tavakolafshari J, Mortazavi Y, Biglari A, Mirzaei SA and Nadri S. shRNA-mediated downregulation of &#x3B1;-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines. Iran J Basic Med Sci 2017; 20: 1021-1028."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/foods10081708","article-title":"Non-specific binding and cross-reaction of ELISA: a case study of porcine hemoglobin detection","volume":"10","author":"Jiang","year":"2021","unstructured":"Jiang X, Wu M, Albo J and Rao Q. Non-specific binding and cross-reaction of ELISA: a case study of porcine hemoglobin detection. Foods 2021; 10: 1708.","journal-title":"Foods"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jsbmb.2010.03.061","article-title":"Genomic vitamin D signaling in breast cancer: insights from animal models and human cells","volume":"121","author":"Matthews","year":"2010","unstructured":"Matthews D, LaPorta E, Zinser GM, Narvaez CJ and Welsh J. Genomic vitamin D signaling in breast cancer: insights from animal models and human cells. J Steroid Biochem Mol Biol 2010; 121: 362-367.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref28","unstructured":"Gonzalez-Sancho JM, Larriba MJ, Ordonez-Moran P, Palmer HG and Munoz A. Effects of 1&#x3B1;, 25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res 2006; 26: 2669-2681."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10552-023-01845-1","article-title":"Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study","volume":"35","author":"Lindgren","year":"2024","unstructured":"Lindgren H, Ademi D, Godina C, Tryggvadottir H, Isaksson K and Jernstr&#xF6;m H. Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study. Cancer Causes Control 2024; 35: 907-919.","journal-title":"Cancer Causes Control"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43046-024-00215-5","article-title":"Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors","volume":"36","author":"Bahador","year":"2024","unstructured":"Bahador M, Saeedi Nejad M, Dabiri S, Larizadeh MH and Soofiabadi MF. Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors. J Egypt Natl Canc Inst 2024; 36: 12.","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref31","unstructured":"K&#xF6;stner K, Denzer N, M&#xFC;ller CS, Klein R, Tilgen W and Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009; 29: 3511-3536."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10266-018-0383-0","article-title":"Association of vitamin D binding protein and vitamin D receptor gene polymorphisms in Iranian patients with chronic periodontitis","volume":"107","author":"Nazemisalman","year":"2019","unstructured":"Nazemisalman B, Vahabi S, Sabouri E, Hosseinpour S and Doaju S. Association of vitamin D binding protein and vitamin D receptor gene polymorphisms in Iranian patients with chronic periodontitis. Odontology 2019; 107: 46-53.","journal-title":"Odontology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.11138\/ccmbm\/2016.13.3.190","article-title":"The relationship between vitamin D receptor (VDR) polymorphism and the occurrence of osteoporosis in menopausal Iranian women","volume":"13","author":"Dabirnia","year":"2016","unstructured":"Dabirnia R, Mahmazi S, Taromchi A, Nikzad M and Saburi E. The relationship between vitamin D receptor (VDR) polymorphism and the occurrence of osteoporosis in menopausal Iranian women. Clin Cases Miner Bone Metab 2016; 13: 190-194.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref34","unstructured":"Saburi E, Tavakol-Afshari J, Biglari S and Mortazavi Y. Is &#x3B1;-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis. J BUON 2017; 22: 1372-1377."},{"key":"ref35","unstructured":"Gombart AF, Luong QT and Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res 2006; 26: 2531-2542."},{"key":"ref36","unstructured":"Ale Ahmad A, Saburi E, Rajaei T and Mortazavi Y. Taq1 Polymorphism (rs731236) of Vitamin D receptor gene in children with acute lymphoblastic leukemia. Iranian Journal of Blood and Cancer 2017; 9: 116-120."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12934-021-01728-7","article-title":"PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome","volume":"21","author":"VS","year":"2022","unstructured":"Terra VS, Mauri M, Sannasiddappa TH, Smith AA, Stevens MP, Grant AJ, Wren BW and Cuccui J; Glycoengineering of Veterinary Vaccines consortium (GoVV). PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome. Microb Cell Fact 2022; 21: 6.","journal-title":"Microb Cell Fact"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jnci\/94.17.1311","article-title":"Effects of vitamin D3-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis","volume":"94","author":"Kanda","year":"2002","unstructured":"Kanda S, Mochizuki Y, Miyata Y, Kanetake H and Yamamoto N. Effects of vitamin D3-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 2002; 94: 1311-1319.","journal-title":"J Natl Cancer Inst"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/CEJ.0000000000000437","article-title":"Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies","volume":"28","author":"Cattaruzza","year":"2019","unstructured":"Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, Bartolazzi A and Carlesimo M. Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies. Eur J Cancer Prev 2019; 28: 203-211.","journal-title":"Eur J Cancer Prev"},{"key":"ref40","unstructured":"Young MRI and Xiong Y. Influence of vitamin D on cancer risk and treatment: why the variability? Trends Cancer Res 2018; 13: 43-53."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.3390\/ijms23084380","article-title":"The result of vitamin C treatment of patients with cancer: conditions influencing the effectiveness","volume":"23","author":"Hunyady","year":"2022","unstructured":"Hunyady J. The result of vitamin C treatment of patients with cancer: conditions influencing the effectiveness. Int J Mol Sci 2022; 23: 4380.","journal-title":"Int J Mol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-94-017-7215-0_7","article-title":"Prostate specific antigen as a tumor marker in prostate cancer: biochemical and clinical aspects","volume":"867","author":"Salman","year":"2015","unstructured":"Salman JW, Schoots IG, Carlsson SV, Jenster G and Roobol MJ. Prostate specific antigen as a tumor marker in prostate cancer: biochemical and clinical aspects. Adv Exp Med Biol 2015; 867: 93-114.","journal-title":"Adv Exp Med Biol"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Messex JK and Liou GY. Infiltrating immune cells in prostate cancer and their implication in prostate cancer therapy. Urogenital Cancers: An Interdisciplinary Approach. Springer, Cham; Interdisciplinary Cancer Research 2022. pp. 181-198.","DOI":"10.1007\/16833_2022_32"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1593\/tlo.08106","article-title":"Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor, GcMAF","volume":"1","author":"Yamamoto","year":"2008","unstructured":"Yamamoto N, Suyama H and Yamamoto N. Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor, GcMAF. Transl Oncol 2008; 1: 65-72.","journal-title":"Transl Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10529-022-03276-5","article-title":"Current trends in biopharmaceuticals production in Escherichia coli","volume":"44","author":"McElwain","year":"2022","unstructured":"McElwain L, Phair K, Kealey C and Brady D. Current trends in biopharmaceuticals production in Escherichia coli. Biotechnol Lett 2022; 44: 917-931.","journal-title":"Biotechnol Lett"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"17396","DOI":"10.3390\/ijms242417396","article-title":"The molecular aspects of functional activity of macrophage-activating factor GcMAF","volume":"24","author":"Kirikovich","year":"2023","unstructured":"Kirikovich SS, Levites EV, Proskurina AS, Ritter GS, Peltek SE, Vasilieva AR, Ruzanova VS, Dolgova EV, Oshihmina SG, Sysoev AV, Koleno DI, Danilenko ED, Taranov OS, Ostanin AA, Chernykh ER, Kolchanov NA and Bogachev SS. The molecular aspects of functional activity of macrophage-activating factor GcMAF. Int J Mol Sci 2023; 24: 17396.","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/bioengineering6010027","article-title":"coli","volume":"6","author":"Strutton","year":"2019","unstructured":"Strutton B, Jaffe SR, Evans CA, Fowler GJ, Dobson PD, Pandhal J and Wright PC. Engineering pathways in central carbon metabolism help to increase glycan production and improve N-type glycosylation of recombinant proteins in E. coli. Bioengineering (Basel) 2019; 6: 27.","journal-title":"Bioengineering (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"19122","DOI":"10.1038\/s41598-020-75571-y","article-title":"Simple method for large-scale production of macrophage activating factor GcMAF","volume":"10","author":"Nabeshima","year":"2020","unstructured":"Nabeshima Y, Abe C, Kawauchi T, Hiroi T, Uto Y and Nabeshima YI. Simple method for large-scale production of macrophage activating factor GcMAF. Sci Rep 2020; 10: 19122.","journal-title":"Sci Rep"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"103660","DOI":"10.1016\/j.jri.2022.103660","article-title":"Macrophage-activating factor of bovine colostrum promotes phagocytic activity of murine macrophages and bovine phagocytes","volume":"153","author":"Pandey","year":"2022","unstructured":"Pandey Y, Panda BSK, Kamboj A, Alhussien MN, Kapila R and Kumar Dang A. Macrophage-activating factor of bovine colostrum promotes phagocytic activity of murine macrophages and bovine phagocytes. J Reprod Immunol 2022; 153: 103660.","journal-title":"J Reprod Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-022-00411-4","article-title":"Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis","volume":"56","author":"Zangouei","year":"2023","unstructured":"Zangouei AS, Zangoue M, Taghehchian N, Zangooie A, Rahimi HR, Saburi E, Alavi MS and Moghbeli M. Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis. Biol Res 2023; 56: 1.","journal-title":"Biol Res"}],"container-title":["International Journal of Physiology, Pathophysiology and Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/4\/ijppp0161714.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:23Z","timestamp":1766023163000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/4\/ijppp0161714.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/wshw8932","relation":{},"ISSN":["1944-8171"],"issn-type":[{"type":"electronic","value":"1944-8171"}],"subject":[],"published":{"date-parts":[[2025]]}}}